Literature DB >> 1597856

Ester and amide derivatives of E64c as inhibitors of platelet calpains.

Z Huang1, E B McGowan, T C Detwiler.   

Abstract

Ester and amide derivatives of E64c, (+)-(2S,3S)-3-[[(S)-3-methyl-1- [(3-methylbutyl)carbamoyl]butyl]carbamoyl]-2-oxiranecarboxylic acid, an inhibitor of calpains, were synthesized and tested for ability to inhibit calpain in lysed cells, ability to enter intact cells, and ability to inhibit calpain in intact cells. The esters were from halogen-substituted alcohols and alcohols with increasing size. There were no appreciable differences in the inhibitory potency of any of the halogen-substituted esters from ethyl to trifluoroethyl, indicating that ease of hydrolysis of this class of ester is not important for activity. The only ester with impaired activity was the largest, Z-leucyl-norleucyl, which was about 5% as effective as the ethyl ester, E64d. Amides of amino acid esters also had impaired activity. To explore the possibility of targeting E64c derivatives to specific cells, esters and amides of E64c with 5-hydroxytryptamine were tested on the rationale that the active 5-hydroxytryptamine uptake mechanism of platelets might selectively concentrate the drug in platelets. Both the ester and amide inhibited calpain in lysed cells, but only the ester inhibited in intact cells. The 5-hydroxytryptamine ester showed no advantage over the ethyl ester in entering platelets.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1597856     DOI: 10.1021/jm00089a015

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

1.  Potential Alzheimer's Disease Therapeutics Among Weak Cysteine Protease Inhibitors Exhibit Mechanistic Differences Regarding Extent of Cathepsin B Up-Regulation and Ability to Block Calpain.

Authors:  Heather Romine; Katherine M Rentschler; Kaitlan Smith; Ayanna Edwards; Camille Colvin; Karen Farizatto; Morgan C Pait; David Butler; Ben A Bahr
Journal:  Eur Sci J       Date:  2017-10

2.  Catalytic coupling of arene C-H bonds and alkynes for the synthesis of coumarins: substrate scope and application to the development of neuroimaging agents.

Authors:  Paul A Vadola; Dalibor Sames
Journal:  J Org Chem       Date:  2012-07-06       Impact factor: 4.354

3.  Direct measurement of cathepsin B activity in the cytosol of apoptotic cells by an activity-based probe.

Authors:  Matthew R Pratt; Matthew D Sekedat; Kyle P Chiang; Tom W Muir
Journal:  Chem Biol       Date:  2009-09-25

4.  Targeted inhibition of the immunoproteasome is a potent strategy against models of multiple myeloma that overcomes resistance to conventional drugs and nonspecific proteasome inhibitors.

Authors:  Deborah J Kuhn; Sally A Hunsucker; Qing Chen; Peter M Voorhees; Marian Orlowski; Robert Z Orlowski
Journal:  Blood       Date:  2008-12-02       Impact factor: 22.113

5.  Kinetic, Mutational, and Structural Studies of the Venezuelan Equine Encephalitis Virus Nonstructural Protein 2 Cysteine Protease.

Authors:  Xin Hu; Jaimee R Compton; Dagmar H Leary; Mark A Olson; Michael S Lee; Jonah Cheung; Wenjuan Ye; Mark Ferrer; Noel Southall; Ajit Jadhav; Elaine M Morazzani; Pamela J Glass; Juan Marugan; Patricia M Legler
Journal:  Biochemistry       Date:  2016-05-19       Impact factor: 3.162

6.  The in vitro retardation of porcine cataractogenesis by the calpain inhibitor, SJA6017.

Authors:  Suman Biswas; Frederick Harris; Jaipaul Singh; David A Phoenix
Journal:  Mol Cell Biochem       Date:  2004-06       Impact factor: 3.396

Review 7.  Cysteine proteases as therapeutic targets: does selectivity matter? A systematic review of calpain and cathepsin inhibitors.

Authors:  Marton Siklos; Manel BenAissa; Gregory R J Thatcher
Journal:  Acta Pharm Sin B       Date:  2015-09-26       Impact factor: 11.413

8.  Endoplasmic Reticulum-Associated rht-PA Processing in CHO Cells: Influence of Mild Hypothermia and Specific Growth Rates in Batch and Chemostat Cultures.

Authors:  Mauricio Vergara; Julio Berrios; Irene Martínez; Alvaro Díaz-Barrera; Cristian Acevedo; Juan G Reyes; Ramon Gonzalez; Claudia Altamirano
Journal:  PLoS One       Date:  2015-12-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.